A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.

Despite considerable experience with single-dose, live, oral cholera vaccine CVD 103-HgR in Asia, Europe, and the Americas, the vaccine had not been evaluated in sub-Saharan Africa or on individuals infected with human immunodeficiency virus (HIV). We therefore conducted a randomized, placebo-contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perry, R. T., Plowe, C. V., Koumaré, B., Bougoudogo, F., Kotloff, K. L., Losonsky, G. A., Wasserman, S. S., Levine, M. M.
Format: Artigo
Idioma:Inglês
Publicat: World Health Organization 1998
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2305629/
https://ncbi.nlm.nih.gov/pubmed/9615498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars